SECONDARY SCREENING SERVICE

MSI offers a full-service contract research option, through which a customer gains access to a dedicated, highly experienced MSI scientist and BSI instrumentation for an extended period, thereby offering an ‘integrated’ CRO model that delivers high-quality technical expertise to support multiple projects.

While maintaining the advantages of the Assay Development modular project construction and implementation, our Secondary Screening Service effectively gives you an additional FTE to apply to a range of projects.

With a highly experienced contract scientist fully supported with BSI instrumentation as part of your team, you can drive forward your drug discovery in a much reduced time period by:

• Increasing the efficiency of your whole discovery process

• Addressing multiple compounds & targets in parallel

• Undertaking deeper MOA and target-compound characterization

• Guide medicinal chemistry and pharmacology decision making

Contact us to discuss how adding a dedicated MSI scientist to your team could galvanize your membrane-based discovery programs.

Read about our low-risk, high-value Target-Ligand Binding Characterization Process that a majority of the top ten pharmaceutical and biotechnology companies have used to solve drug binding characterization problems impacting early discovery through IND submission.